business
Novo’s Wegovy Pill Wins Approval in UK for Obesity Treatment
Novo Nordisk A/S’s Wegovy pill was approved in the UK, opening up the obesity market to people who are wary of taking a shot.
Read full story on Bloomberg Markets → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop